These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 3676728)
21. Effects of protein-modifying reagents on brain tryptamine binding sites: possible involvement of a thiol group in temperature-induced high-affinity [3H]tryptamine binding sites. Serikyaku S; Saito M; Ishitani R Jpn J Pharmacol; 1990 Jan; 52(1):51-7. PubMed ID: 1968519 [TBL] [Abstract][Full Text] [Related]
22. Differential effects of chronic antidepressant treatment on 5-HT1C receptor binding sites in Wistar rat brain. Hulihan-Giblin BA; Park YD; Aulakh CS Eur J Pharmacol; 1994 Sep; 263(1-2):213-6. PubMed ID: 7821356 [TBL] [Abstract][Full Text] [Related]
23. [Effect of solubilization by methylethylketone of rat liver mitochondrial monoamine oxidase on inhibition by clorgyline and deprenyl of the enzyme activity]. Severina IS; Klimova GI; Nersisian AA Biokhimiia; 1981 Nov; 46(11):2043-55. PubMed ID: 6797482 [TBL] [Abstract][Full Text] [Related]
24. Treatment with clorgyline and pargyline differentially decreases clonidine-induced hypotension and bradycardia. Gutkind JS; Enero MA Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(3):189-92. PubMed ID: 6493360 [TBL] [Abstract][Full Text] [Related]
25. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration. Green AR; Youdim MB Br J Pharmacol; 1975 Nov; 55(3):415-22. PubMed ID: 1203627 [TBL] [Abstract][Full Text] [Related]
26. Binding of [3H]brofaromine to monoamine oxidase A in vivo: displacement by clorgyline and moclobemide. Waldmeier PC; Stöcklin K Eur J Pharmacol; 1990 May; 180(2-3):297-304. PubMed ID: 2365007 [TBL] [Abstract][Full Text] [Related]
27. The effect of repeated doses of (-) deprenyl on the dynamics of monoaminergic transmission. Comparison with clorgyline. Zsilla G; Földi P; Held G; Székely AM; Knoll J Pol J Pharmacol Pharm; 1986; 38(1):57-67. PubMed ID: 3020531 [TBL] [Abstract][Full Text] [Related]
28. Biochemical characterization of [3H]tryptamine binding sites from rat brain. Brüning G; Rommelspacher H Biochem Int; 1989 Jan; 18(1):227-33. PubMed ID: 2541722 [TBL] [Abstract][Full Text] [Related]
29. Serotonin binding in mouse brains. Some methodological aspects. Marcusson J; Oreland L; Winblad B J Neural Transm; 1983; 56(4):251-63. PubMed ID: 6308144 [TBL] [Abstract][Full Text] [Related]
30. Clonazepam-induced up-regulation of serotonin1 and serotonin2 binding sites in rat frontal cortex. Wagner HR; Reches A; Yablonskaya E; Fahn S Adv Neurol; 1986; 43():645-51. PubMed ID: 2418653 [TBL] [Abstract][Full Text] [Related]
31. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl]. Severina IS Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561 [TBL] [Abstract][Full Text] [Related]
32. Functional evidence that chronic drugs induce adaptive changes of central autoreceptors regulating serotonin release. Maura G; Raiteri M Eur J Pharmacol; 1984 Jan; 97(3-4):309-13. PubMed ID: 6705828 [TBL] [Abstract][Full Text] [Related]
33. Tryptamine receptors: neurochemical and electrophysiological evidence for postsynaptic and functional binding sites. van Nguyen T; Paterson IA; Juorio AV; Greenshaw AJ; Boulton AA Brain Res; 1989 Jan; 476(1):85-93. PubMed ID: 2563335 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of monoamine oxidase isoforms modulates nicotine withdrawal syndrome in the rat. Malin DH; Moon WD; Goyarzu P; Barclay E; Magallanes N; Vela AJ; Negrete AP; Mathews H; Stephens B; Mills WR Life Sci; 2013 Oct; 93(12-14):448-53. PubMed ID: 23988853 [TBL] [Abstract][Full Text] [Related]
35. Temperature-sensitive high affinity [3H]tryptamine binding sites in rat brain. Karasawa A; Serikyaku S; Ishitani R Life Sci; 1986 Apr; 38(14):1331-7. PubMed ID: 3083170 [TBL] [Abstract][Full Text] [Related]
36. Comparative Analysis of the Neurochemical Profile and MAO Inhibition Properties of N-(Furan-2-ylmethyl)-N-methylprop-2-yn-1-amine. De Deurwaerdère P; Binda C; Corne R; Leone C; Valeri A; Valoti M; Ramsay RR; Fall Y; Marco-Contelles J ACS Chem Neurosci; 2017 May; 8(5):1026-1035. PubMed ID: 27977122 [TBL] [Abstract][Full Text] [Related]
37. Effects of gestational exposure to monoamine oxidase inhibitors in rats: preliminary behavioral and neurochemical studies. Whitaker-Azmitia PM; Zhang X; Clarke C Neuropsychopharmacology; 1994 Oct; 11(2):125-32. PubMed ID: 7840864 [TBL] [Abstract][Full Text] [Related]
38. Correlation of changes in alpha 2-adrenoceptor number and locomotor responses to clonidine following clorgyline discontinuation. Aulakh CS; Cohen RM; McLellan C; Murphy DL Br J Pharmacol; 1983 Sep; 80(1):10-2. PubMed ID: 6317126 [TBL] [Abstract][Full Text] [Related]
39. The [3H]tryptamine receptor in human brain: kinetics, distribution, and pharmacologic profile. Mousseau DD; Butterworth RF J Neurochem; 1994 Sep; 63(3):1052-9. PubMed ID: 8051546 [TBL] [Abstract][Full Text] [Related]
40. [Effect of protein denaturing reactions on retardation of the activity of rat liver mitochondrial monoamine oxidase by clorgyline and deprenyl]. Severina IS Biokhimiia; 1983 Sep; 48(9):1513-21. PubMed ID: 6414536 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]